Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Unleasing Viruses aimed at Killing Cancer.
View:
Post by askretka on Feb 12, 2024 10:03am

Unleasing Viruses aimed at Killing Cancer.

From 10 Nov 2023

https://regenerativemedicineblog.mayoclinic.org/2023/11/10/unleashing-viruses-aimed-at-killing-cancer/

"
Loading the oncolytic virus onto CAR-T cells may give us three levels of killing. First, the CAR-T cells target the tumor and kill some of the cells," says Dr. Vile. "Next, it delivers the oncolytic virus, which infects tumor cells, replicates and kills them. Third, that alerts the immune system of the patient to the fact that there's something majorly wrong. The immune system starts to see the cancer and starts to react against it and kill it."


Cheers!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Comment by CMHarring218431 on Feb 12, 2024 11:13am
Are you substituting for Noteable. Just kidding. Even though Pancan went into quiet mode but said Onc would still receive the 5 million dollar award .....should we assume it was included in MC's 12 million dollar cash on hand. The PR wasn't entirely clear as to whether the money would be just handed over as a reward for past successes or if it would be set aside to be used in further ...more  
Comment by canadafan on Feb 12, 2024 12:06pm
The $5 million was directly related towards the additional trial arm. To be added alongside the other Pancreatic cancer arms. My opinion, not just sitting in the piggy bank as part of company cash. I could  be wrong. Howevr the PanCan " grant" was clear.
Comment by CMHarring218431 on Feb 12, 2024 12:15pm
So, good....if they ever get going we have another 5 million to contribute to funding additional trial alongside BP. Thanks
Comment by Buckhenry on Feb 12, 2024 2:05pm
I predict that the pumpers will make a prediction.... odds my prediction will come true?
Comment by 13X2413 on Feb 12, 2024 2:09pm
Pumpers have moved on. 
Comment by Buckhenry on Feb 12, 2024 2:28pm
They could be in a 90 day black out period...
Comment by 13X2413 on Feb 12, 2024 3:03pm
First Noteable, then Azzak. Gone with the wind. Strange timing. Very quiet here now. Kind of nice. 
Comment by Buckhenry on Feb 12, 2024 3:18pm
If and/or when any good news comes out the pumpers will jump on here and take all the credit like stink on a skunk. 
Comment by canadafan on Feb 12, 2024 12:02pm
There are mutiple good study results with the last 12 months. Yes, there have been ample failures. That is part of the biotech world. Even the best & biggest pharma companies have mutiple failures. Years ago I was invited to be part of a phase 2 trial,  interviews, massive forms to fill out. More interviews.  For mostly time availability reasons I dropped out before the first ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities